Latest news
MedInsights partners with Biologie Fonctionnelle et Adaptative (BFA) from Université Paris Cité to Advance Neuro-metabolic and addictive disorder research
PARIS, FRANCE – August 8, 2025 - MedInsights has announced a long-term partnership with the Biologie Fonctionnelle et Adaptative (BFA) laboratory at Université Paris Cité. This collaboration will leverage MedInsights' proprietary Nexus-Rx engine to accelerate the discovery of new therapies for neurometabolic and compulsive/addictive disorders.
The project will use MedInsights' AI and machine learning tools to identify potential drug compounds that can target a specific, yet poorly understood, kinase enzyme linked to these conditions. The goal is to both deepen the understanding of this enzyme's role and validate the predictive power of AI in generating effective therapeutic targets.
This partnership, which begins in August 2025, highlights MedInsights' commitment to working with leading research institutions to develop groundbreaking, data-driven solutions for complex diseases.
The complete press release can be found here PDF document.
​
Content Information : Manish Sarkar, business development, manish.sarkar@medinsights.fr
​
​
​
​
​
​